Navigation Links
ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
Date:2/25/2008

WELLESLEY HILLS, Mass., Feb. 25 /PRNewswire/ -- Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, as a result of growing interest from prospective buyers, announced today a development strategy for further advancement of the company's proprietary benzoxazinorifamycins as leading antibacterial drug candidates in combination antibiotic therapy. Rifalazil is the most developed of these compounds, though most of the interest for combination antibiotics has centered on novel compounds or new chemical entities ("NCEs").

Combination antibiotic therapy has been used as the treatment of choice for certain stubborn bacterial infections. Two prime examples are tuberculosis and gastric ulcer disease, caused by Mycobacterium tuberculosis infection and Helicobacter pylori infection, respectively. In both of these examples, the rifamycins rifampin and rifabutin have been used because of their potency against these pathogens. However, these rifamycins share the negative attribute of eliciting drug-drug interactions; that is, they interfere with the actions of many other medications that the patient may require. The NCEs are breakthrough drug candidates because they have not been shown preclinically to engender drug-drug interactions caused by the other rifamycins. In addition the NCEs have equal or superior potency compared with rifampin.

There is increasing recognition that rifamycins (e.g. rifampin and ABI- 0043) are highly efficacious against implant-associated staphylococcal infection. This property is due to their excellent efficacy against non- growing and surface-adhering staphylococci. No other class of antimicrobial agents shares this property. In view of the growing number of patients with implants (artificial joints, internal fixation devices, vascular grafts etc.) there is an urgent need for this type of antibiotic. "The development of an NCE for combination antibiotic treatment could be extremely beneficial," comm
'/>"/>

SOURCE ActivBiotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ActivBiotics Outlines a Clinical Path Forward to Examine if Rifalazil Is Superior to Azithromycin in the Treatment of Chlamydia STD
2. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
3. ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting
4. Cancer Cure Coalition Proposes Major Changes at the FDA
5. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
6. Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine
7. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
8. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
9. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
10. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
11. Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...NGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences...hromboticaptamerswithactivecontrolagents,announced...gatthePiperJaffray21stAnnualHealthCareConferenceat...ntationwillbegivenat1:10pm(EST)onTuesday,December1...emphasisontheleaddevelopmentprogram,theanticoagula...
(Date:11/25/2009)...CITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,I...uringpoint-of-carebloodanalysissystems,announcedto...cer,willpresentatthe21stAnnualPiperJaffrayHealthCa....TheconferencewillbeheldattheNewYorkPalaceHotelinN...ps,manufacturesandmarketsportablebloodanalysissyst...
(Date:11/25/2009)...LHILL,N.C.,Nov.25/PRNewswire/--CempraPharmaceutica...dentandchiefexecutiveofficer,willpresentatthePiper...,December1,2009,atTheNewYorkPalaceHotelinNewYorkCi...twoleadingantibioticclinicalprogramsforthetreatmen...outCempraPharmaceuticals ,, Foundedin2006,Cemp...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Heavy Periods May Be Due to a Clotting Disorder 48094 1Heavy Periods May Be Due to a Clotting Disorder 48094 2New Debt Securities of US Oncology Inc 48091 1New Debt Securities of US Oncology Inc 48091 2New Debt Securities of US Oncology Inc 48091 3NxStage Announces Closing of 2440 Million Debt Financing with Asahi Kasei Kuraray Medical 48089 1NxStage Announces Closing of 2440 Million Debt Financing with Asahi Kasei Kuraray Medical 48089 2
... July 06, 2007 -- DOR BioPharma,Inc. (OTCBB: <a t...nt.com/Engine?Account=iwire&PageName=QUOTE&...ent.com/Engine?Account=iwire&PageName=QUOTE&am...ounced today that the European Patent,Office has g...d to,oral vaccination using mutated non-toxic form...
...07 /PRNewswire-FirstCall/ --,Genzyme Corp. announc... 3 clinical studies to assess the safety and effic...ntibiotic, polymer,therapy for patients with Clost...econd Phase 3 study of tolevamer liquid is fully,e..., In this first Phase 3 study known as the Polymer...
Other Medicine Technology:DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4
(Date:11/26/2009)...t,s too big or too heavy can lead to strains or wo...s) -- There may be nothing wrong with stuffing you...to do the same thing with your suitcase as you pac...were treated in 2008 in U.S. hospital emergency ro...acilities for luggage-related injuries, such as mu...
(Date:11/26/2009)... Dr. David Kim of the Live Life Agai... in Dallas , is one of a growing number of physici...tworking sites to connect with individuals who are...ight morbid obesity. Dr. Kim is utilizing Facebook...about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering...ers of Yaz and Yasmin birth control pills who have...Embolism, Stroke, Heart Attack or other related ca...en can call toll free at 1-800-856-6405 or go to t...m and fill out an online case evaluation form. ,...
(Date:11/25/2009)...RYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-- Ony...thatthecompanywillhosttwoinvestoreventsinDecember:...a.m.CT/10:00a.m.ET ,, Principalinvestigatorsw...nrelapsedand/orrefractorymultiplemyeloma,asfeature...etingandExpositioninNewOrleans,LA.Theteleconferenc...
(Date:11/25/2009)...GBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmeal...rsinthegreaterLongBeachareathankstoFaithInAction/V...nceatHome(IAH),adivisionofSCANHealthPlan.Formoreth...olunteerstodeliverwarmThanksgivingmealstoseniorsin...LosAngelesandsurroundingcities. ,, "Ourwarmholi...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...BOTHELL, Wash., June 11 Cardiac Science,(Nasdaq: ...osis,resuscitation, rehabilitation, and informatic...ification for its HeartCentrix(R) ECG informatics,...ajor player in electronic health systems, with mor...
..., WESTCHESTER, Ill. A research abstract that wil...d Annual Meeting of the Associated Professional Sl...sleep and healthy aging. , The study, authored by...use of sleeping aids, daytime somnolence, napping,...
..., WESTCHESTER, Ill. A cognitive behavioral inter...n significantly improve insomnia in adults, accord...on Wednesday at SLEEP 2008, the 22nd Annual Meetin...articipants (mostly female) with an average age of...
...Ranking Among the Top Healthcare IT Providers Unde...hcare and Life Sciences Industry, TEANECK, N.J., ...der of global consulting, technology and business,...5th annual survey of major healthcare information ...
...REDONDO BEACH, Calif., June 11 Function Drinks ha... the brand,s position as a,leading innovator in th...a,proprietary PET bottle based on cutting-edge tec...nal platforms," said Dayton Miller, Function Drink...
..., WASHINGTON, DC Contrary to the popular percept...ciological research from the June issue of the Am...nal women,s employment rates have continually push...nomenon described in mass media reports, sociologi...
Other Medicine News:Health News:HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records 2Health News:HeartCentrix Informatics Solution from Cardiac Science Now Certified with Allscripts Electronic Health Records 3Health News:Normal sleep linked to successful aging 2Health News:A self-help program delivered online can improve insomnia in adults 2Health News:Cognizant Ranks #11 on Healthcare Informatics 100 List 2Health News:Cognizant Ranks #11 on Healthcare Informatics 100 List 3Health News:Function Drinks Unveils New Proprietary Packaging 2Health News:Opting out revolution a myth: Study shows steep employment gains for women, mothers 2Health News:Opting out revolution a myth: Study shows steep employment gains for women, mothers 3
...from Thermo Labsystems was designed specifically t...ce. Advanced features such as the new fast dial s...lumes help to define this as a new leader in singl... plate offers a custom fit for different hand size...
...ries 2000 Pipette is a synonym for pipetting accur... and superior operating comfort. Its single, multi... stroke and blow-out as well as eject the tip. Pro...es utmost accuracy and precision. Ejection sleeve ...
Variable Volume Pipette H2
...fers improved ergonomics for today's exacting labo...py finger rest and the large display windows enhan...gitals also feature soft-touch tip ejection with p...per blow-out for 0.2 - 50ul micro volume pipetting...
Medicine Products: